84
MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Embed Size (px)

Citation preview

Page 1: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY

JianYu Rao, M.D.Associate professor of pathology and epidemiology

UCLA

Page 2: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Molecular Biology - Outline

• Introduction

• Basic Principles of Molecular Biology

• Core Techniques of Molecular Biology

• High Throughput Technologies

• Epigenetics – DNA Methylation

Page 3: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

INTRODUCTION

• 1953 - Discovery of DNA double helix (Crick & Watson)

• 1960s - DNA transcription mechanism• 1970s - Recombinant DNA technology• 1980s - PCR • 1990s - Human genome project/DNA chips• 2000 – Genome Wide Association (GWA)

Studies

Page 4: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Basic Principles of Molecular Biology

• DNA structure

– 4 bases (nucleotide): 2 pyrimidines thymine (T) and cytosine (C), and 2 purines adenine (A) and guanine (G)

– Form double helix by base-paring through H-bond (A to T and G to C) and a backbone consists of sugars and phosphate.

– The strands have polarity (3’ to 5’ or vice versa) and are complementary to each other.

Page 5: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– Genetic information is organized lineally:

• A codon is the basic unit with 3 consecutive nucleotides that specifies a single aa.

• A gene is a segment of DNA (with lineally linked multiple codeons) that specifies a protein.

• A chromosome contains several thousands genes and is the smallest replicating unit (human has 46 chromosomes).

• The genome is the entire set of information that an organism contains.

5’ 3’

5' –CCT GGT CCT CTG ACT GCT - 3'

K H L …

Page 6: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Basic Principles of Molecular Biology (cont.)

• Gene structure

– Gene is compose of a upstream 5’ regulatory region (TATA box or CAAT box), several exons (expressed gene sequences), and intervening intrones (nonexpressed sequence).

– There are a total of 100,000 genes estimated in mammalian genome.

– Less than 30% of the genome is ever transcribed into RNA, and only a fraction of that is translated into protein.

Page 7: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– More than 70% of entire genome is not transcribed and is composed of many stretches of repetitious sequences that can repeat on scales of 5-10 bp, to 5000-6000 bp. Species specific type of repeats, termed Alu sequences, are useful as markers for identifying genes transferred between species.

– A gene family are a number of closely linked genes that code for structurally and functionally related proteins.

Page 8: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Basic Principles of Molecular Biology (Cont.)

• Gene transcription (DNA to mRNA)

– mRNA (message RNA) is the template for protein synthesis.

– Only the exon sequences of a given gene is transcribed.

– Transcription begins by binding of RNA polymerase II on initiation site. This process requires a transcription factor which is a protein recognizing the region of DNA to be transcribed.

Page 9: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– A “primary transcript” which ranges from the initiation site to a termination site (including all the exons and introns) is produced initially, followed by adding a cap (methylated G) at 5’ end and a Poly A tail at 3’end, and finally by several steps of splicing (cut off the introns).

– The produced mature mRNA is then exported from nuclear to cytoplasm by unknown mechanisms for translation.

Page 10: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Basic Principles of Molecular Biology (Cont.)

• Translation (mRNA to protein)

– The translation is taken place in cytoplasm, in ribosomes.

– Proteins are further modified by post-translational modification steps, including proteolytic cleavage, addition of carbohydrate or lipid motifs, and modification of a.a..

• Gene expression in a cell is influenced by both the micro (surrounding cell, tissue, organ) and macro (endocrine and paracrine) environments.

Page 11: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques

• Restriction Endonucleases– Enzymes found in bacteria that

cleave DNA at precise sequences.– Named by the organisms of origin

(eg. EcoRI is from E Coli R strain).

– Size of fragments produced is a function of the number of the bases in the restriction site. (eg., 4 cutters produce DNA into smaller fragments while 8 cutters produce gene-sized DNA fragments).

Page 12: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Hybridization

– Based on the property of DNA base paring (A to T and G to C).

– The principle is the recognition of a complementary sequence (gene to be detected) by a short sequence (Probe) .

• The two strands of targeted DNA needs to be separated into single strands by a process of melting at first, followed by annealing (reform the double strand) after adding the probe.

Page 13: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– The annealing depends on several factors, including DNA concentration, the time, the temperature, and the concentration of salts. The stringency of annealing is a function of temperature and salt concentration.

– Examples:• Dot or slot blot• In situ hybridization (FISH, gene or

chromosome)• Northern or Southern blot

– Needs to know the DNA sequence to be fished.

Page 14: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Electrophoresis

– A technique to separate nucleic acids and proteins by size and charge.

– All electrophoretic techniques are carried out using a supporting gel of controlled pore size.

– Most separations are by size of moleculars (large one stay, the small one migrate), while the charge governs the actual migration of the moleculars.

• Polyacrylamide - for small noncharged moleculars (DNA)

• Agarose - for large noncharged moleculars (DNA/RNA)

• urea and SDS - for charged moleculars (protein)

Page 15: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– Procedure:• Making a gel and buffers (loading and running

buffers)

• Apply sample into the well

• Apply voltage (100 to 1000s depends on the size of gel)

• Visualize and detection (staining the gel, or transfer the moleculars into membranes)

Page 16: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Sourthern blot - for DNA (RFLP)

• Northern blot - for RNA

• Western blot - for protein

Page 17: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 18: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 19: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Isolation of DNA and RNA– It is crucial to have pure source of DNA or RNA for the accurate

analysis.

– The purity is indicated by the ratio of OD reading (OD 260 vs 280, which measures nucleic acids vs protein, respectively)

– RNA is much less stable than DNA, due to the widely present RNases.

– The major method for DNA isolation is the phenol-chloroform extraction (phenol allows dissociation of DNA from protein, whereas chloroform promotes the protein denaturation). Followed by separation with centrifugation, the DNA is present at upper phase.

Page 20: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– The major method for mRNA isolation is by modified phenol-chloroform method that requires a inhibition of RNase using guanidinium and a purification step using either oligo(dT) chromatography or beads.

– Source of DNA can be any fresh or archived small amount materials (paraffin blocks, trace amount of old blood, saliva, etc), while mRNA usually requires large amounts of fresh or immediately frozen samples.

Page 21: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• PCR (Polymerase Chain Reaction)– Revolutionize the detection

technique for nucleic acids (DNA and RNA), also useful for cloning and site-directed mutagenesis.

– The principle is by cycling the temperature changes from denaturation (95 C), annealing (50C), and hybridization (70C), it allows a molecular (single stranded) to replicate itself exponentially.

– Requires primers, DNA polymerase, nucleoside triphosphates, and magnesium ion.

Page 22: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– Limitations of PCR:• Primer selectivity• Primer dimer formation• Contamination• Nonspecific priming• Temperature design for GC rich or AT rich genes (incomplete

melting or incomplete annealing, respectively).

– In epidemiological studies it is used for detecting the presence/absence of genes (DNA or RNA), measures the level of genes, or detect the specific forms of mutations, etc.

Page 23: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Examples of Variant PCR– LCR (for detection of point mutation)

– Competitive PCR (for quantification of DNA copy #)

– RT-PCR (for mRNA detection and quantification)

– SSCP (for screening of gene mutation)

– In situ PCR

– TRAP (for telomerase activity detection)

– Real-Time PCR

Page 24: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• Monoclonal Antibodies– Or so called immunoglobulins, are antibodies capable of recognizing only

one specific antigen (epitope).

– Developed by various techniques e.g., hybridoma, Phgae-display, etc.

– Used in molecular epidemiological studies to detect any protein products (such as oncogene products, growth factors, receptors, etc) in a highly specific and often quantitative manner by various methods such as ELISA, EIA, immunohistochemistry, immunocytochemistry, etc.

Page 25: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

– All these methods are basically use the same principle, i.e.,antigen-antibody reaction. They can be either direct (without amplification step) or indirect (with amplification steps)and a detection step (with enzyme colormatrix or fluorescence).

• 3 steps immunofluorescence to detect a tumor specific antigen M344

– Step 1: Incubate cells with McAb (mouse anti human) against M344

– Step 2: Incubate with biotinlated Goat (or rabbit) anti mouse IgG (amplification)

– Step 3: Incubate with streptavidin-Texas Red (amplification/detection)

Page 26: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

QFIABiomarker Profile

G-actin: Texas-Red conjugated DNase I

M344: FITC (or Rhodamin) 3-Step

Immunofluorescence DNA: Hoechst or DAPI

Page 27: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Core Techniques (Cont.)

• RFLP - Microsattelite marker - SNP– RFLP is the method to detect alterations (mutation) of one

specific gene.– Microsattelite markers are simple tandem repeat polymorphisms of

several locus, which replaces RFLP as markers for disease– SNP - are single nucleotide variants of entire genome - therefore

are much more powerful and may replace Microsattelite markers or RFLP as markers of disease

• More prevalent in the genome than microsattelites in genome• Some SNPs located in genes directly affect protein structure or

expression levels• More stably inherited• Better for high throughput analysis

Page 28: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

SNPs - Definition

“Single base pair positions in genomic DNA at which different sequence alternatives (alleles) exist in normal individuals in some population, wherein the least frequent allele has an abundance of 1% or greater” (Brookes, Gene, 1999).

Page 29: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

How to Define SNPS?

Conventional way: • develop sequence tagged sites (STS)

• identify DNA sequence variants

• estimate allele frequencies of the marker

• place the marker in human genome

• obtain DNA sequence

More powerful – Genome Wide Association Studies (GWA)

Page 30: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Genome Wide Association (GWA) Study

• Help to identified genetic susceptibility markers for cancer– Prostate: Chromosome 8q24 (Gudundsson, et al, Nature

genetics/Yeager, et al, Nature Genetics, 2007)

– Lung: Chromosome 15q25 (nicotinic acetylcholine receptor subunits) (Huang, et al, Nature 2008/Amos, et al, Nature Genetics, 2008/Thorgerisson, et al, Nature genetic, 2008)

• Genes identified in these locus may also be the targets for chemopreventive drug development

Page 31: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

High Throughput Techniques

• Microarray technology– DNA chips

• cDNA array format• in situ synthesized oligonucleotide format (Affymetrix)

– Proteomics– Tissue arrays

• These are powerful tools and high through put methods to study gene expression, but they are not the answers themselves

• Individual targets/patterns identified need to be validated• In epidemiological studies, these methods can be used to

identify specific exposure induced molecular changes, individual risk assessments, etc.

Page 32: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

An example of our 9000 gene mouse-arrays using differential expression analysis with Cy3 and Cy5 fluorescent dyes.

Page 33: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Proteomics• Examine protein level expression in a high throughput manner

• Used to identify protein markers/patterns associated with disease/function

• Different formats:– SELDI-TOF (laser desorption ionization time-of-flight): the protein-chip

arrays, the mass analyzer, and the data-analysis software

– 2D Page coupled with MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight)

– Antibody based formats

Page 34: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 35: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

A, GTE (20g/ml)M

W

(kD

a)pI

4.5 9.53.5 5.1 5.5 6.0 7.0 8.4217

30

37

98

55

20

116

3

4

12

5

6 7

8 9 10

3

4

12

5

6 7

8 9

10

11 13

12

11 13

1214

15

14

15

16 16 1818

17 17

48 hr

GTE: -Time: 48 hr

+24 hr

+

MW

(k

Da)

217

30

37

98

55

20

116

1110

1713

2019

5 1

13

18

17

10 15

12

15

16 12 1614

11

15

14

4

18

pIB, GTE (40g/ml)

4.5 9.53.5 5.1 5.5 6.0 7.0 8.4 4.5 9.53.5 5.1 5.5 6.0 7.0 8.4

4.5 9.53.5 5.1 5.5 6.0 7.0 8.4 4.5 9.53.5 5.1 5.5 6.0 7.0 8.4 4.5 9.53.5 5.1 5.5 6.0 7.0 8.4

Fig 1

Page 36: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Tissue Array• Provide a new high-throughput tool for the study of gene dosage

and protein expression patterns in a large number of individual tissues for rapid and comprehensive molecular profiling of cancer and other diseases, without exhausting limited tissue resources.

• A typical example of a tissue array application is in searching for oncogenes amplifications in vast tumor tissue panels. Large-scale studies involving tumors encompassing differing stages and grades of disease are necessary to more efficiently validate putative markers and ultimately correlate genotypes with phenotypes.

• Also applicable to any medical research discipline in which paraffin-embedded tissues are utilized, including structural, developmental, and metabolic studies.

Page 37: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Bladder Array

HE

Gelsolin

Page 38: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

DNA Methylation

DNA methylation plays an important role in normal cellular processes, including X chromosome inactivation, imprinting control and transcriptional regulation of genes

It predominantly found on cytosine residues in CpG dinucleotide, CpG island, to producing 5-Methylcytosine

CpG islands frequently located in or around the transcription sites

Page 39: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Source:Royal Society of Chemistry

DNA Methylation (Cont’d)

Aberrant DNA methylation are one of the most common features of human neoplasia

Two major potential mechanisms for aberrant DNA

methylation in tumor carcinogenesis

Silencing tumor suppressor genes (e.g. p16 gene)

Point mutation: C to T transition

(e.g. P53 gene)

Page 40: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Promoter-Region Methylation

Promoter-region CpG islands methylation• Is rare in normal cells

• Occur virtually in every type of human neoplasm

• Associate with inappropriate transcriptional silence

• Early event in tumor progression

In tumor suppressor genes

Most of the tumor suppressor genes are under-methylated in normal cells but methylated in tumor cells. Methylation is often correlated with an decreasing level of gene

expression and can be found in premalignant lesions

Page 41: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

DNA methyltransferases DNA methyltransferases

DNMTs catalyze the transfer of a methyl group (CH3) from S-

adenosylmethionine (SAM) to the carbon-5 position of cytosine producing the 5-methylcytosine

There are several DNA methyltransferases had been discovered, including DNMT1, 3a, and 3b

Page 42: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Pathology - Objective

• To learn basic histopathological terminology.

• To know different types of tumor.

Page 43: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

What is the difference between “tumor” vs “cancer”

Tumor – Either benign or malignant

Cancer – Usually malignant

Page 44: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Classification of Tumors

-Based on histological origin (epithelial, mesenchyme, etc..)

-Based on biological behavior

(benign vs malignant)

Page 45: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

PATHOLOGICAL REPORT

• Tumor histological type.

• Tumor stage.

• Tumor grade.

• Other features (size, % necrosis, lymphovascular invasion…)

Page 46: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

CANCER HISTOLOGICAL TYPE

• Three Major Categories:– Epithelial – “Carcinoma”– Mesenchyme – “Sarcoma”– Hematopoitic – “Leukemia/Lymphoma”

• Other Minor Categories:– Nevocytic – “Melanoma”– Germ cell – Teratoma, Seminoma, Yolk sac tumor,

Choriocarcinoma, etc…– Endocrine/Neuro – Carcinoid/Insulinoma/small cell

carcinoma, etc…

Page 47: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

CARCINOMA

• Squamous – Squamous Cell Carcinoma.

• Glandular - Adenocarcinoma.

• Transitional – Transitional Cell Carcinoma.

• Small cell – Small cell carcinoma

Page 48: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

SARCOMA

• Muscle – Smooth muscle: Leiomyosarcoma– Skeletal muscle: Rhabdomyosarcoma

• Fat – Liposarcoma

• Skeleton – Osteosarcoma

• Cartilage – Chondrosarcoma

Page 49: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Classification of tumor according to

their morphologic features (histology)

• Morphologic classification refers to the histologic classification made by pathologist based on microscopic examination.

Page 50: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Benign vs Malignant Tumor

• The main distinction between benign and malignant tumor is:– Malignant tumor has invasion and metastatic

potential whereas benign tumor does not.– Malignant tumor has features of abnormal

cellular differentiation whereas benign tumor usually not.

Page 51: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 52: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 53: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Why histologic classification is important in cancer epidemiology?

• Cancer is not ONE disease

• Different cancer types of same organ may have different exposure etiology, pathogenesis, as well as behavior, i.e., HETEROGENEITY

Page 54: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Carcinoma

• Carcinoma (Cancer of the epithelium) 85%

Epithelium is the term applied to the cells that cover the external surface of the body or that line the internal cavities, plus those cells derived from the linings that form glands.

Page 55: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Why most common cancers are epithelial origin?

• These cells are the first point of contact of the body with environmental substances, either directly (squamous cells) or indirectly (glandular cells).

• Epithelial cells usually have fast turn over rate, i.e., fast cell division, and their DNA can be damaged by carcinogens more often than non-dividing cells.

Page 56: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Carcinoma: Squamous cell

• Originates from stratified squamous epithelium of the skin, mouth, esophagus, and vagina, as well as from areas of squamous metaplasia, as in the bronchi or squamocolumnar junction of the uterine cervix. SCC is marked by the production of keratin.

Page 57: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Skin Cancer

Page 58: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

                                                                                          

Squamous Cell Carcinoma

Page 59: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Carcinoma, Transitional Cell

• Transitional cell carcinoma - arise from the transitional cell epithelium of the urinary tract, such as bladder.

Page 60: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 61: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 62: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

transitional cell carcinoma of the urothelium is shown here at low power to reveal the frond-like papillary projections of the tumor above the surface to the left. It is differentiated enough to resemble urothelium, but is a mass. No invasion to the right is seen at this point.

Page 63: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

TCC at high power

Page 64: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Carcinoma: Adenocarcinoma

• Adenocarcinoma - is carcinoma of glandular epithelium and includes malignant tumors of the gastrointestinal mucosa, endometrium, and pancreas; and is often associated with desmoplasia, tumor-induced proliferation of non-neoplastic fibrous connective tissue, particularly in adenocarcinoma of the breast, pancreas, and prostate.

Page 65: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Prostate Ca

Ovarian Ca

Page 66: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Sarcoma

• Sarcoma is a malignant tumor of mesenchymal origin

• Sarcoma is often used with a prefix that denotes the tissue of origin of the tumor, as in osteosarcoma (bone), leiomyosarcoma (smooth muscle), rhabdomyosarcoma (skeletal muscle), and liposarcoma (fatty tissue).

Page 67: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Classification of tumor according to stage

Page 68: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Stage

• -is clinical assessment of the degree of localization or spread of the tumor.

• -generally correlated better with prognosis than dose histopathologic grading.

• -is examplified by the generalized TNM system, which evaluates size and extent of tumor (T), lymph node involvement (N), and metastasis (M).

• -different staging systems (WHO, TNM, etc), sometimes oriented toward specific tumors, e.g., Dukes system for colorectal carcinomas.

Page 69: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 70: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA
Page 71: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Classification of Tumor according to its differentiation

(grade)

Page 72: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Grade of Disease

• Grading is histo-pathologic evaluation of the lesion based on the degree of cellular differentiation and nuclear features:

  Well Differentiated (Grade I) – more resemble to normal tissue/cell

Moderately differentiated (Grade II)- less resemblance of normal tissue/cell

Undifferentiated (Grade III)- lost resemblance to normal tissue/cell

Page 73: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Gleason's breakthrough was to develop a reproducible description of the glandular architecture, to which one assigns a score from 1 to 5. The pathologist looks for a major pattern and a minor pattern to give a Gleason sum between 2 and 10. On the left is a picture adapted from Gleason's 1977 article demonstrating the changes in gland pattern as one goes from grade 1 to grade 5 cancer. The glands in grade 1 cancer are small and round. Grade 5 cancer is hardly forming glands at all.

Page 74: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Benign Prostate: Hyperplasia

Page 75: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

                                             

Gleason Grade 1 Prostate Cancer

                                                                                                                                         

Page 76: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

                                             

Gleason Grade 1 Prostate Cancer

Page 77: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

                                             

At right is Gleason 3 CaP. The glands are irregularly shaped. They are mixed in with some normal glands. This tumor is infiltrating the prostate.

                                             At higher magnification, there are nests of glands with no intervening stroma. This is characteristic of higher grade CaP

Page 78: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

                                               The cells are not organized into glands, but are infiltrating the prostate as cords.                                            

Here is Gleason 5, or poorly differentiated cancer. You can see that it is invading the seminal vesicle (stage T4)

Page 79: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Precursors

from intraepithelial neoplasia (IN)

to carcinoma in situ (CIS)

Page 80: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

NORMAL CIN 1 CIN 2 CIN 3

NORMAL LGSIL HG SIL HGSIL

Page 81: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Important for Epidemiologist • Study nature history of disease progression

• Study genetic/environmental factors associate with disease progression

• Develop tools for risk assessment/early detection

• Targets for chemoprevention

Page 82: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Cancer

Precancerous Intraepithelial Lesions, (PIN, CIN, PaIN..)

Birth

Genetic Suscep. Marker

Markers for Exposure

Markers ofEffect

Tumor Markers

Exposure to Carcinogen Additional Molecular Event

Surrogate End Point Markers

CHEMOPREVENTION

Page 83: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

SUMMARY

• The key is to understand tumor hetergeneity:– Human cancer is not one disease , but many different

types of diseases (Disease heterogeneity).– The same type/stage/grade of tumor may behave

differently in different person (Behavior heterogeneity).– Even within the same tumor, there are may be different

histological appearances and molecular expressions/changes (Expression heterogeneity).

• As an epidemiologist, we should know the basic features of the disease, and design studies accordingly

Page 84: MOLECULAR BIOLOGY & PATHOLOGY IN EPIDEMIOLOGY JianYu Rao, M.D. Associate professor of pathology and epidemiology UCLA

Thank You!